Recently we showed that 24 h after copulation to satiety, there is a reduction in androgen receptor density (ARd) in the medial preoptic area (MPOA) and in the ventromedial hypothalamic nucleus (VMH), but not in the bed nucleus of the stria terminalis (BST). The present study was designed to analyze whether the ARd changes in these and other brain areas, such as the medial amygdala (MeA) and lateral septum, ventral part (LSV), were associated with changes in sexual behavior following sexual satiety. Males rats were sacrificed 48 h, 72 h or 7 days after sexual satiety (4 h ad libitum copulation) to determine ARd by immunocytochemistry; additionally, testosterone serum levels were measured in independent groups sacrificed at the same intervals. In another experiment, males were tested for recovery of sexual behavior 48 h, 72 h or 7 days after sexual satiety. The results showed that 48 h after sexual satiety 30% of the males displayed a single ejaculation and the remaining 70% showed a complete inhibition of sexual behavior. This reduction in sexual behavior was accompanied by an ARd decrease exclusively in the MPOA-medial part (MPOM). Seventy-two hours after sexual satiety there was a recovery of sexual activity accompanied by an increase in ARd to control levels in the MPOM and an overexpression of ARd in the LSV, BST, VMH and MeA. Serum testosterone levels were unmodified during the post-satiety period. The results are discussed on the basis of the similarities and discrepancies between ARd in specific brain areas and male sexual behavior.

Keywords:
Sexual recovery after satiety, Medial preoptic area, Lateral septum, Medial amygdala, Ventromedial hypothalamic nucleus, Androgen receptor immunocytochemistry
1.
Buvat J: Hormones and male sexual behavior: physiological and physiopathological data. Contracept Fertil Sex 1996;24:767–778.
2.
Lee HJ, Chang C: Recent advances in androgen receptor action. Cell Mol Life Sci 2003;60:1613–1622.
3.
Kempainen JA, Lane MV, Sar M, Wilson EM: Androgen receptor phosphorylation, turnover, nuclear transport and transcriptional activation. Specificity for steroids and antihormones. J Biol Chem 1992;267:968–974.
4.
Syms AJ, Norris JS, Panko WB, Smith RG: Mechanism of androgen-receptor augmentation. Analysis of receptor synthesis and degradation by the density-shift technique. J Biol Chem 1985;260:455–461.
5.
Prins GS, Birch L, Greene GL: Androgen receptor localization in different cell types of the adult rat prostate. Endocrinology 1991;129:3187–3199.
6.
Fernández-Guasti A, Kruijver FP, Fodor M, Swaab DF: Sex differences in the distribution of androgen receptors in the human hypothalamus. J Comp Neurol 2000;425:422–435.
7.
Fernández-Guasti A, Swaab D, Rodriguez-Manzo G: Sexual behavior reduces hypothalamic androgen receptor immunoreactivity. Psychoneuroendocrinology 2003;28:501–512.
8.
Lynch CS, Story AJ: Dihydrotestosterone and estrogen regulation of rat brain androgen-receptor immunoreactivity. Physiol Behav 2000;69:445–453.
9.
Wood RI, Newman SW: Intracellular partitioning of androgen receptor immunoreactivity in the brain of the male Syrian hamster: effects of castration and steroid replacement. J Neurobiol 1993;24:925–938.
10.
Iqbal J, Swanson JJ, Prins GS, Jacobson CD: Androgen-receptor like immunoreactivity in the Brazilian opossum brain and pituitary: distribution and effects of castration and testosterone replacement in the adult male. Brain Res 1995;703:1–18.
11.
Smith GT, Brenowitz EA, Prins GS: Use of PG-21 immunocytochemistry to detect androgen receptors in the songbird brain. J Histochem Cytochem 1996;44:1075–1080.
12.
McGinnis MY, Montana RC, Lumia AR: Effects of hydroxyflutamide in the medial preoptic area or lateral septum on reproductive behavior of male rats. Brain Res Bull 2002;59:227–234.
13.
Greco B, Edwards DA, Zumpe D, Clancy AN. Androgen receptor and mating-induced fos immunoreactivity are co-localized in limbic and midbrain neurons that project to the male rat medial preoptic area. Brain Res 1998;781:15–24.
14.
Meisel RL, Sachs BD: The physiology of male sexual behavior in Knobil E, Neill J (eds): The Physiology of Reproduction. New York, Raven Press, 1994, pp 3–105.
15.
Pfaus JG, Heeb MM: Implications of immediate-early gene induction in the brain following sexual stimulation of female and male rodents. Brain Res Bull 1997;44:397–407.
16.
Beach FA, Jordan L: Sexual exhaustion and recovery in the male rat. J Comp Physiol Psychol 1956;8:121–133.
17.
Larsson K: The effects of sexual satiation; in Elmgren J (ed): Conditioning and Sexual Behaviour in the Male Rat. Stockholm, Almqvist and Wiksell, 1956, pp 101–116.
18.
Rodríguez-Manzo G, Fernández-Guasti A: Reversal of sexual exhaustion by serotonergic and noradrenergic agents. Behav Brain Res 1994;62:127–134.
19.
Van Furth WR, Wolterink G, Van Ree JM: Regulation of masculine sexual behaviour: involvement of brain opioids and dopamine. Brain Res Rev 1995;21:162–184.
20.
Harding SM, McGinnis, MY: Effects of testosterone in the VMN on copulation, partner preference and vocalizations in male rats. Horm Behav 2003;43:327–335.
21.
Coolen LM, Peters HJ, Veening JG: Distribution of Fos immunoreactivity following mating versus anogenital investigation in the male rat brain. Neuroscience 1997;77:1151–1161.
22.
Paredes RG: Medial preoptic/anterior hypothalamus and sexual motivation. Scand J Psychol 2003;44:203–212.
23.
McGinnis MY, Williams GW, Lumia AR: Inhibition of male sexual behavior by androgen receptor blockade in preoptic area or hypothalamus, but not amygdala or septum. Physiol Behav 1996;60:783–789.
24.
Gulia KK, Kumar VM, Mallick HN: Role of the septal noradrenergic system in the elaboration of male sexual behavior in rats. Pharmacol Biochem Behav 2002;72:817–823.
25.
Phillips BV, Fernández-Guasti A: c-Fos expression specifically related to sexual satiety in the male rat forebrain. Physiol Behav, submitted.
26.
Portillo W, Díaz NF, Antonio Cabrera E, Fernández-Guasti A, Paredes RG: Comparative analysis of immunoreactive cells for androgen receptors and estrogen receptors alpha in copulating and non-copulating male rats. J Neuroendocrinol 2006;18:168–176.
27.
Phillips-Farfán BV, Lemus AE, Fernández-Guasti A: Increased estrogen receptor alpha immunoreactivity in the forebrain of sexually satiated rats. Horm Behav, in press.
28.
Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates, ed 4. San Diego, Academic Press, 1998, pp 17–31.
29.
Bonilla-Jaime H, Vázquez-Palacios G, Arteaga-Silva M, Retana-Márquez S: Hormonal responses to different sexually related conditions in male rats. Horm Behav 2006;49:376–382.
30.
Handa RJ, Kerr JE, DonCarlos LL, McGivern RF, Hejna G: Hormonal regulation of androgen receptor messenger RNA in the medial preoptic area of the male rat. Brain Res Mol Brain Res 1996;39:57–67.
31.
Kruijver FP, Fernandez-Guasti A, Fodor M, Kraan EM, Swaab DF: Sex differences in androgen receptors of the human mamillary bodies are related to endocrine status rather than to sexual orientation or transsexuality. J Clin Endocrinol Metab 2001;86:818–827.
32.
Lu S, McKenna SE, Cologer-Clifford A, Nau EA, Simon NG: Androgen receptor in mouse brain: sex differences and similarities in autoregulation. Endocrinology 1998;139:1594–1601.
33.
Tyagi RK, Lavrovsky Y, Ahn SC, Song CS, Chatterjee B, Roy AK: Dynamics of intracellular movements and nucleocytoplasmic recycling of the ligand-activated receptor in living cells. Mol Endocrinol 2000;14:1162–1174.
34.
Menard CS, Harlan RE: Up-regulation of androgen receptor immunoreactivity in the rat brain by androgenic-anabolic steroids. Brain Res 1993;622:226–236.
35.
Schneider JS, Burgess C, Sleiter NC, DonCarlos LL, Lydon JP, O’Malley B, Levine JE: Enhanced sexual behavior and androgen receptor immunoreactivity in the male progesterone receptor knockout mouse. Endocrinology 2005;146:4340–4348.
36.
Kokontis JM, Liao S: Molecular action of androgen in the normal and neoplastic prostate. Vitam Horm 1999;55:219–307.
37.
Kolvisto P, Kononen J, Palmberg C, Tammela T, Hyytinen E, Isola J, Trapman J, Cleutjens K, Noordzij A, Visakorpi T, Kalloniemi OP: Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res 1997;57:314–319.
38.
Meek LR, Romeo RD, Novak CM, Sisk CL: Actions of testosterone in prepubertal and postpubertal male hamsters: dissociation of effects on reproductive behavior and brain androgen receptor immunoreactivity. Horm Behav 1997;31:75–88.
39.
Chambers KC, Thornton JE, Roselli CE: Age-related deficits in brain androgen binding and metabolism, testosterone, and sexual behavior of male rats. Neurobiol Aging 1991;12:123–130.
40.
McGinnis MY, Dreifuss RM: Evidence for a role of testosterone–androgen receptor interactions in mediating masculine sexual behavior in male rats. Endocrinology 1989;124:618–626.
41.
Balfour ME, Brown JL, Yu L, Coolen LM: Potential contribution of efferents from medial prefrontal cortex to neural activation following sexual behavior in the male rat. Neuroscience 2006;137:1259–1276.
42.
Baum MJ, Tobet SA, Starr MS, Bradshaw WG: Implantation of dihydrotestosterone propionate into the lateral septum or medial amygdala facilitates copulation in castrated male rats given estradiol systemically. Horm Behav 1982;16:208–223.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.